GB2258613B - Pharmaceutical diltiazem formulation - Google Patents

Pharmaceutical diltiazem formulation

Info

Publication number
GB2258613B
GB2258613B GB9215980A GB9215980A GB2258613B GB 2258613 B GB2258613 B GB 2258613B GB 9215980 A GB9215980 A GB 9215980A GB 9215980 A GB9215980 A GB 9215980A GB 2258613 B GB2258613 B GB 2258613B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical
diltiazem formulation
diltiazem
formulation
pharmaceutical diltiazem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB9215980A
Other versions
GB9215980D0 (en
GB2258613A (en
Inventor
Ian Richard Buxton
Helen Critchley
Stewart Thomas Leslie
Sandra Therese Antoi Malkowska
Derek Allan Prater
Ronald Brown Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919117361A external-priority patent/GB9117361D0/en
Priority claimed from GB919122967A external-priority patent/GB9122967D0/en
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Priority to GB9215980A priority Critical patent/GB2258613B/en
Publication of GB9215980D0 publication Critical patent/GB9215980D0/en
Publication of GB2258613A publication Critical patent/GB2258613A/en
Application granted granted Critical
Publication of GB2258613B publication Critical patent/GB2258613B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9215980A 1991-08-12 1992-07-28 Pharmaceutical diltiazem formulation Expired - Lifetime GB2258613B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9215980A GB2258613B (en) 1991-08-12 1992-07-28 Pharmaceutical diltiazem formulation

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919117361A GB9117361D0 (en) 1991-08-12 1991-08-12 Oral dosage form
GB919122967A GB9122967D0 (en) 1991-10-29 1991-10-29 Pharmaceutical composition
GB9215980A GB2258613B (en) 1991-08-12 1992-07-28 Pharmaceutical diltiazem formulation

Publications (3)

Publication Number Publication Date
GB9215980D0 GB9215980D0 (en) 1992-09-09
GB2258613A GB2258613A (en) 1993-02-17
GB2258613B true GB2258613B (en) 1996-01-10

Family

ID=27265807

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9215980A Expired - Lifetime GB2258613B (en) 1991-08-12 1992-07-28 Pharmaceutical diltiazem formulation

Country Status (1)

Country Link
GB (1) GB2258613B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3264722B2 (en) * 1993-02-25 2002-03-11 第一製薬株式会社 Capsule preparation
US7060734B1 (en) 1997-09-09 2006-06-13 Alza Corporation Pharmaceutical coating composition and method of use
ES2232021T3 (en) 1997-09-09 2005-05-16 Alza Corporation COMPOSITION FOR PHARMACEUTICAL COATING AND USE PROCEDURE.

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2091203A (en) * 1981-01-19 1982-07-28 Tanabe Seiyaku Co Method of preparing microcapsules
EP0076428A1 (en) * 1981-10-05 1983-04-13 Tanabe Seiyaku Co., Ltd. Microcapsules and method of preparing same
EP0149920A2 (en) * 1983-12-22 1985-07-31 ELAN CORPORATION, Plc Pharmaceutical formulation
WO1988002253A1 (en) * 1986-09-30 1988-04-07 Roberto Valducci Coating membrane and compositions prepared therefrom
EP0288732A2 (en) * 1987-04-28 1988-11-02 E.R. Squibb & Sons, Inc. New pharmaceutical compositions in the form of beadlets and method
EP0322277A1 (en) * 1987-12-21 1989-06-28 Synthelabo Sustained release pharmaceutical composition
EP0340105A1 (en) * 1988-04-27 1989-11-02 Sanofi Diltiazem microspheres, process for producing, and sustained pharmaceutical release compositions containing them
EP0373417A1 (en) * 1988-11-30 1990-06-20 Schering Corporation Sustained release diltiazem formulation
EP0446753A1 (en) * 1990-03-06 1991-09-18 Vectorpharma International S.P.A. Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films and their preparation process

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2091203A (en) * 1981-01-19 1982-07-28 Tanabe Seiyaku Co Method of preparing microcapsules
EP0076428A1 (en) * 1981-10-05 1983-04-13 Tanabe Seiyaku Co., Ltd. Microcapsules and method of preparing same
EP0149920A2 (en) * 1983-12-22 1985-07-31 ELAN CORPORATION, Plc Pharmaceutical formulation
WO1988002253A1 (en) * 1986-09-30 1988-04-07 Roberto Valducci Coating membrane and compositions prepared therefrom
EP0288732A2 (en) * 1987-04-28 1988-11-02 E.R. Squibb & Sons, Inc. New pharmaceutical compositions in the form of beadlets and method
EP0322277A1 (en) * 1987-12-21 1989-06-28 Synthelabo Sustained release pharmaceutical composition
EP0340105A1 (en) * 1988-04-27 1989-11-02 Sanofi Diltiazem microspheres, process for producing, and sustained pharmaceutical release compositions containing them
EP0373417A1 (en) * 1988-11-30 1990-06-20 Schering Corporation Sustained release diltiazem formulation
EP0446753A1 (en) * 1990-03-06 1991-09-18 Vectorpharma International S.P.A. Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films and their preparation process

Also Published As

Publication number Publication date
GB9215980D0 (en) 1992-09-09
GB2258613A (en) 1993-02-17

Similar Documents

Publication Publication Date Title
PH30666A (en) Diltiazem pharmaceutical spheroid formulation
ZA923272B (en) Pharmaceutical formulations
GB9114950D0 (en) Pharmaceutical formulation
GB2269382B (en) Pharmaceutical compounds
GB9103824D0 (en) Formulation
GB9103302D0 (en) Pharmaceutical formulations
SG49144A1 (en) Pharmaceutical formulation
GB9216061D0 (en) Pharmaceutical combination formulation
GB2258613B (en) Pharmaceutical diltiazem formulation
GB9112974D0 (en) Pharmaceutical formulation
GB9122114D0 (en) Pharmaceutical formulation
GB9121798D0 (en) Pharmaceutical formulation
GB9116467D0 (en) Pharmaceutical formulation
GB9122115D0 (en) Pharmaceutical formulation
GB9120675D0 (en) Formulation
GB9104946D0 (en) Formulation
GB9125953D0 (en) Formulation
GB9108281D0 (en) Formulation
GB9221694D0 (en) Pharmaceutical formulation
GB9212968D0 (en) Pharmaceutical formulation
GB9102019D0 (en) Pharmaceutical formulations
GB9124803D0 (en) Pharmaceutical formulations
GB9114621D0 (en) Pharmaceutical formulations
GB9103444D0 (en) Pharmaceutical formulations
GB9125005D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Expiry date: 20120727